Skip to main content

Advertisement

Log in

Risk factors associated with HPV persistence after conization in high-grade squamous intraepithelial lesion

  • Review
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

Objective

Persistence of HPV infection in patients with high-grade squamous intraepithelial lesion (HSIL) undergoing cervical excision is considered strongly associated with the recurrence and progression of cervical dysplasia. This study aims to review potential risk factors for persistence of HPV infection in patients with HSIL, thus optimizing the postoperative monitoring program and clinical treatment.

Methods

Through literature review, published data about estimated prognostic risk factors for persistence of HPV infection in patients with HSIL after conization within two decades were searched and analyzed, and their references were manually reviewed as well.

Results

Women with persistence of HPV infection after cervical excision were at an extremely high risk of disease recurrence and progression to cervical cancer. Some clinicopathological and even physiological elements involving viral, organic human body and treatment factors, such as human papillomavirus (HPV) 16, high viral load, age older than 50 years and positive surgical margin were of prognostic significance in persistent HPV infection in patients with HSIL, yet some of which still remained controversial.

Conclusions

Monitoring prognostic factors in women with persistence of HPV infection who have underwent cervical excision for HSIL are of great significance, especially the follow-up within 2 years postoperatively, which significantly improves the clinical outcome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Li N, Franceschi S, Howell-Jones R, Snijders PJ, Clifford GM (2011) Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication. Int J Cancer 128:927–935

    Article  CAS  PubMed  Google Scholar 

  2. Kilic D, Guler T, Atigan A, Avsaroglu E, Karakaya YA, Kaleli I, Kaleli B (2020) Predictors of Human papillomavirus (HPV) persistence after treatment of high grade cervical lesions; does cervical cytology have any prognostic value in primary HPV screening? Ann Diagn Pathol 49:151626

    Article  PubMed  Google Scholar 

  3. Guan P, Howell-Jones R, Li N, Bruni L, de Sanjose S, Franceschi S, Clifford GM (2012) Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer. Int J Cancer 131:2349–2359

    Article  CAS  PubMed  Google Scholar 

  4. Huang HJ, Tung HJ, Yang LY, Chao A, Tang YH, Chou HH, Chang WY, Wu RC, Huang CC, Lin CY, Liao MJ, Chen WC, Lin CT, Chen MY, Huang KG, Wang CJ, Chang TC, Lai CH (2021) Role of human papillomavirus status after conization for high-grade cervical intraepithelial neoplasia. Int J Cancer 148:665–672

    Article  CAS  PubMed  Google Scholar 

  5. Yu Y, Han L, Yu W, Duan Y, Li F (2017) High risk factors associated with HPV persistence after loop electrosurgical excision procedure in patients with intraepithelial neoplasia. Int J Clin Exp Pathol 10:1817–1824

    CAS  Google Scholar 

  6. Bogani G, Pinelli C, Chiappa V, Martinelli F, Lopez S, Ditto A, Raspagliesi F (2020) Age-specific predictors of cervical dysplasia recurrence after primary conization: analysis of 3212 women. J Gynecol Oncol 31:e60

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Ouh YT, Cho HW, Kim SM, Min KJ, Lee SH, Song JY, Lee JK, Lee NW, Hong JH (2020) Risk factors for type-specific persistence of high-risk human papillomavirus and residual/recurrent cervical intraepithelial neoplasia after surgical treatment. Obstet Gynecol Sci 63:631–642

    Article  PubMed  PubMed Central  Google Scholar 

  8. Hoffman SR, Le T, Lockhart A, Sanusi A, Dal Santo L, Davis M, McKinney DA, Brown M, Poole C, Willame C, Smith JS (2017) Patterns of persistent HPV infection after treatment for cervical intraepithelial neoplasia (CIN): a systematic review. Int J Cancer 141:8–23

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Pirtea L, Grigoras D, Matusz P, Pirtea M, Moleriu L, Tudor A, Ilina R, Secosan C, Horhat F, Mazilu O (2016) Human papilloma virus persistence after cone excision in women with cervical high grade squamous intraepithelial lesion: a prospective study. Can J Infect Dis Med Microbiol 2016:3076380

    Article  PubMed  PubMed Central  Google Scholar 

  10. Bruno MT, Cassaro N, Garofalo S, Boemi S (2019) HPV16 persistent infection and recurrent disease after LEEP. Virol J 16:148

    Article  PubMed  PubMed Central  Google Scholar 

  11. Pirtea L, Grigoras D, Matusz P, Pirtea M, Moleriu L, Tudor A, Ilina R, Secosan C, Horhat F, Mazilu O (2016) Age and HPV type as risk factors for HPV persistence after loop excision in patients with high grade cervical lesions: an observational study. BMC Surg 16:70

    Article  PubMed  PubMed Central  Google Scholar 

  12. Friebe K, Klapdor R, Hillemanns P, Jentschke M (2017) The value of partial hpv genotyping after conization of cervical dysplasias. Geburtshilfe Frauenheilkd 77:887–893

    Article  PubMed  PubMed Central  Google Scholar 

  13. So KA, Lee IH, Kim TJ, Lee KH (2019) Risk factors of persistent HPV infection after treatment for high-grade squamous intraepithelial lesion. Arch Gynecol Obstet 299:223–227

    Article  PubMed  Google Scholar 

  14. Nam K, Chung S, Kim J, Jeon S, Bae D (2009) Factors associated with HPV persistence after conization in patients with negative margins. J Gynecol Oncol 20:91–95

    Article  PubMed  PubMed Central  Google Scholar 

  15. Kim YT, Lee JM, Hur SY, Cho CH, Kim YT, Kim SC, Kang SB (2010) Clearance of human papillomavirus infection after successful conization in patients with cervical intraepithelial neoplasia. Int J Cancer 126:1903–1909

    Article  CAS  PubMed  Google Scholar 

  16. Ayhan A, Tuncer HA, Reyhan NH, Kuscu E, Dursun P (2016) Risk factors for residual disease after cervical conization in patients with cervical intraepithelial neoplasia grades 2 and 3 and positive surgical margins. Eur J Obstet Gynecol Reprod Biol 201:1–6

    Article  PubMed  Google Scholar 

  17. Peitsaro P, Johansson B, Syrjänen S (2002) Integrated human papillomavirus type 16 is frequently found in cervical cancer precursors as demonstrated by a novel quantitative real-time PCR technique. J Clin Microbiol 40:886–891

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Schiffman M, Rodriguez AC, Chen Z, Wacholder S, Herrero R, Hildesheim A, Desalle R, Befano B, Yu K, Safaeian M, Sherman ME, Morales J, Guillen D, Alfaro M, Hutchinson M, Solomon D, Castle PE, Burk RD (2010) A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia. Cancer Res 70:3159–3169

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Gage JC, Schiffman M, Solomon D, Wheeler CM, Gravitt PE, Castle PE, Wentzensen N (2013) Risk of precancer determined by HPV genotype combinations in women with minor cytologic abnormalities. Cancer Epidemiol Biomark Prev 22:1095–1101

    Article  CAS  Google Scholar 

  20. Costa S, De Simone P, Venturoli S, Cricca M, Zerbini ML, Musiani M, Terzano P, Santini D, Cristiani P, Syrjänen S, Syrjänen K (2003) Factors predicting human papillomavirus clearance in cervical intraepithelial neoplasia lesions treated by conization. Gynecol Oncol 90:358–365

    Article  PubMed  Google Scholar 

  21. Liang Y, Chen M, Qin L, Wan B, Wang H (2019) A meta-analysis of the relationship between vaginal microecology, human papillomavirus infection and cervical intraepithelial neoplasia. Infect Agent Cancer 14:29

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Ghosh I, Muwonge R, Mittal S, Banerjee D, Kundu P, Mandal R, Biswas J, Basu P (2017) Association between high risk human papillomavirus infection and co-infection with Candida spp. and Trichomonas vaginalis in women with cervical premalignant and malignant lesions. J Clin Virol 87:43–48

    Article  CAS  PubMed  Google Scholar 

  23. Zheng JJ, Song JH, Yu CX, Wang F, Wang PC, Meng JW (2019) Difference in vaginal microecology, local immunity and HPV infection among childbearing-age women with different degrees of cervical lesions in Inner Mongolia. BMC Womens Health 19:109

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  24. De Bernardis F, Graziani S, Tirelli F, Antonopoulou S (2018) Candida vaginitis: virulence, host response and vaccine prospects. Med Mycol 56:26–31

    Article  PubMed  CAS  Google Scholar 

  25. Mitra A, MacIntyre DA, Ntritsos G, Smith A, Tsilidis KK, Marchesi JR, Bennett PR, Moscicki AB, Kyrgiou M (2020) The vaginal microbiota associates with the regression of untreated cervical intraepithelial neoplasia 2 lesions. Nat Commun 11:1999

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Wang X, Zhao Y, Zou X, Wang L (2020) Relationship of P16 and Ki67 in recurrence of HPV infection and cervical intraepithelial neoplasia. Int J Clin Exp Pathol 13:3174–3180

    CAS  PubMed  PubMed Central  Google Scholar 

  27. Branca M, Ciotti M, Santini D, Di Bonito L, Giorgi C, Benedetto A, Paba P, Favalli C, Costa S, Agarossi A, Alderisio M, Syrjänen K (2004) p16(INK4A) expression is related to grade of cin and high-risk human papillomavirus but does not predict virus clearance after conization or disease outcome. Int J Gynecol Pathol 23:354–365

    Article  CAS  PubMed  Google Scholar 

  28. Terra APS, Murta EFC, Maluf PJ, Caballero OLSD, Brait M, Adad SJ (2007) Aberrant promoter methylation can be useful as a marker of recurrent disease in patients with cervical intraepithelial neoplasia grade III. Tumori J 93:572–579

    Article  CAS  Google Scholar 

  29. Zhang H, Zhang TG, You ZB, Zhang YZ (2015) Positive surgical margin, HPV persistence, and expression of both TPX2 and PD-L1 are associated with persistence/recurrence of cervical intraepithelial neoplasia after cervical conization. Plos One 10:e0142868

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  30. Acladious NN, Sutton C, Mandal D, Hopkins R, Zaklama M, Kitchener H (2002) Persistent human papillomavirus infection and smoking increase risk of failure of treatment of cervical intraepithelial neoplasia (CIN). Int J Cancer 98:435–439

    Article  CAS  PubMed  Google Scholar 

  31. Sarian LO, Derchain SF, Pitta Dda R, Morais SS, Rabelo-Santos SH (2004) Factors associated with HPV persistence after treatment for high-grade cervical intra-epithelial neoplasia with large loop excision of the transformation zone (LLETZ). J Clin Virol 31:270–274

    Article  PubMed  Google Scholar 

  32. Boscolo-Rizzo P, Furlan C, Lupato V, Polesel J, Fratta E (2017) Novel insights into epigenetic drivers of oropharyngeal squamous cell carcinoma: role of HPV and lifestyle factors. Clin Epigenetics 9:124

    Article  PubMed  PubMed Central  Google Scholar 

  33. van der Waal D, Bekkers RLM, Dick S, Lenselink CH, Massuger L, Melchers WJG, Schmeink CE, Siebers AG, Broeders MJM (2020) Risk prediction of cervical abnormalities: the value of sociodemographic and lifestyle factors in addition to HPV status. Prev Med 130:105927

    Article  PubMed  Google Scholar 

  34. Delmas MC, Larsen C, van Benthem B, Hamers FF, Bergeron C, Poveda JD, Anzen B, van den Hoek A, Meier F, Pena JM, Savonius H, Sperandeo D, Suligoi B, Vernazza P, Brunet JB (2000) Cervical squamous intraepithelial lesions in HIV-infected women: prevalence, incidence and regression. European study group on natural history of HIV infection in women. AIDS 14:1775–1784

    Article  CAS  PubMed  Google Scholar 

  35. Elfgren K, Jacobs M, Walboomers JM, Meijer CJ, Dillner J (2002) Rate of human papillomavirus clearance after treatment of cervical intraepithelial neoplasia. Obstet Gynecol 100:965–971

    PubMed  Google Scholar 

  36. Liu G, Sharma M, Tan N, Barnabas RV (2018) HIV-positive women have higher risk of human papilloma virus infection, precancerous lesions, and cervical cancer. AIDS 32:795–808

    Article  PubMed  Google Scholar 

  37. Wang XHI, Huang FY, Zhang SL (2017) Loop electrosurgical excision procedure vs. cold knife cone in treatment of cervical intraepithelial neoplasia: review of 447 cases. Ann Clin Lab Sci 47:663–667

    PubMed  Google Scholar 

  38. Hurtado-Roca Y, Becerra-Chauca N, Malca M (2020) Efficacy and safety of cryotherapy, cold cone or thermocoagulation compared to LEEP as a therapy for cervical intraepithelial neoplasia: systematic review. Rev Saude Publica 54:27

    Article  PubMed  PubMed Central  Google Scholar 

  39. Rizzuto I, Nalam M, Jiang J, Linder A, Rufford B (2018) Risk factors for HPV persistence and cytology anomalies at follow-up after treatment for cervical dysplasia. Int J Gynaecol Obstet 141:240–244

    Article  PubMed  Google Scholar 

  40. Alonso I, Torne A, Puig-Tintore LM, Esteve R, Quinto L, Campo E, Pahisa J, Ordi J (2006) Pre- and post-conization high-risk HPV testing predicts residual/recurrent disease in patients treated for CIN 2–3. Gynecol Oncol 103:631–636

    Article  PubMed  Google Scholar 

  41. Paraskevaidis E, Lolis ED, Koliopoulos G, Alamanos Y, Fotiou S, Kitchener HC (2000) Cervical intraepithelial neoplasia outcomes after large loop excision with clear margins. Obstet Gynecol 95:828–831

    CAS  PubMed  Google Scholar 

  42. Fonseca BO, Possati-Resende JC, Salcedo MP, Schmeler KM, Accorsi GS, Fregnani JHTG, Antoniazzi M, Pantano NP, Santana IVV, Matsushita GM, Dos Reis R (2021) topical imiquimod for the treatment of high-grade squamous intraepithelial lesions of the cervix: a randomized controlled trial. Obstet Gynecol 137:1043–1053

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Stier E (2003) Cervical neoplasia and the HIV-infected patient. Hematol-Oncol Clin North Am 17:873

    Article  PubMed  Google Scholar 

  44. Kovachev SM (2020) Immunotherapy in patients with local HPV infection and high-grade squamous intraepithelial lesion following uterine cervical conization. Immunopharmacol Immunotoxicol 42:314–318

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

LZ: project development, data collection, manuscript writing. YH: supervision.

Corresponding author

Correspondence to Yan Hu.

Ethics declarations

Conflict of interest

All authors have no conflict of interest for this article.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zang, L., Hu, Y. Risk factors associated with HPV persistence after conization in high-grade squamous intraepithelial lesion. Arch Gynecol Obstet 304, 1409–1416 (2021). https://doi.org/10.1007/s00404-021-06217-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-021-06217-1

Keywords

Navigation